Dispatch Bio just dropped $216M to tackle one of cancer’s toughest problems: solid tumors. Their secret weapon? A ‘universal’ CAR T therapy using a Flare platform that tags and weakens tumors so the immune system can actually fight back. This could work on tons of different cancers—seriously, 90% of them! Big names like Bristol Myers Squibb and Penn’s Carl June are in on this, and human trials are set for 2026. Is this the game-changer cancer treatment needed? #Health #BodyHealth #CancerResearch